Erlotinib as a salvage treatment for patients with advanced non-small cell lung cancer after failure of gefitinib treatmentCHINESE MEDICAL JOURNALIF7.32011-08-0513PRE
Pemetrexed monotherapy versus pemetrexed plus platinum combination as second-line treatment for advanced non-small cell lung cancerCHINESE MEDICAL JOURNALIF7.32009-10-206PRE